SCHEMBL19769372

SCHEMBL19769372

CCn1c2ccccc2c2ccc3c(c4ccccc4n3Cc3ccc4c5ccccc5n(C)c4c3)c21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.46
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HSD17B10 Q99714 2/20 0.46
MAPT P10636 8/20 0.44
TP53 P04637 8/20 0.44
TSHR P16473 1/20 0.43
CYP19A1 P11511 1/20 0.41
MAPK1 P28482 2/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
HBB P68871 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
THRB P10828 1/20 0.41
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19769430 0.95 TP53 (0.49) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL19769393 0.91 MAPT (0.49) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL19797649 0.89 HPGD (0.49) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL19797648 0.89 HPGD (0.49) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL19769913 0.89 HPGD (0.51) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL19797663 0.86 HPGD (0.54) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL15964263 0.86 GPR3 (0.50) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL19769371 0.85 TP53 (0.56) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL19769912 0.85 TP53 (0.53) HPGDKDM4EALDH1A1HSD17B10MAPT
SCHEMBL19797655 0.84 CYP19A1 (0.44) HPGDKDM4EALDH1A1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180019409-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180019409-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OR51E2, OXER1 HPGD 1323/4885KDM4E 4452/4885ALDH1A1 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.